JPRN-UMIN000052145招募中未知
Treatment for hematological diseases and its effect to anti-SARS-CoV-2 antibody. - Treatment for hematological diseases and its effect to anti-SARS-CoV-2 antibody.
Blood Disorders Center, Aiiku Hospital0 个研究点目标入组 500 人开始时间: 2023年9月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are judged to be ineligible for the study.
研究者
相似试验
已完成
Unknown
To study the clinical features, causative agent and hematological profile in patients of acute febrile illness with low platelet count ( less than 150k)CTRI/2023/09/057471Dr Naveen Kumar120
进行中（未招募）
不适用
Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation RELAZA - RELAZAEUCTR2006-001040-31-DEniversity of Technology Dresden
尚未招募
不适用
Assessment of a remote symptom monitoring in haematological cancer patients - a randomised controlled trialMonitoring symptoms in haematological cancer patientsCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - Leukaemia - Chronic leukaemiaCancer - Hodgkin'sACTRN12611000186954Peter MacCallum Cancer Centre320
尚未招募
Unknown
Change in blood parameters after treatment in Children with Attention Deficit/Hyperactivity Disorder.CTRI/2023/11/059629Governement Medical College and Hospital
已完成
不适用
The effect of treating patients with anaemia in diabetic nephropathy to different target haemoglobin levels with epoetin betaAnaemia in diabetic nephropathyHaematological DisordersAnaemiaISRCTN66395033Barts and the London NHS Trust (UK)160